Ming Hsieh
Ming Hsieh immigrated to the U.S. from China and became a successful technology entrepreneur. He currently serves as Chairman and CEO of Fulgent Therapeutics, a cancer medication research-and-development company. Mr. Hsieh has distinguished himself has a benefactor of the arts and education, with transformative contributions to the University of Southern California to advance engineering and medical research. He graduated from USC and is a Trustee.